7,107 Shares in Transcat, Inc. (NASDAQ:TRNS) Bought by Semanteon Capital Management LP

Semanteon Capital Management LP acquired a new position in shares of Transcat, Inc. (NASDAQ:TRNS) in the 4th quarter, HoldingsChannel reports. The fund acquired 7,107 shares of the scientific and technical instruments company’s stock, valued at approximately $777,000.

Several other large investors have also modified their holdings of the company. Conestoga Capital Advisors LLC boosted its holdings in Transcat by 0.6% in the 4th quarter. Conestoga Capital Advisors LLC now owns 762,861 shares of the scientific and technical instruments company’s stock valued at $83,404,000 after purchasing an additional 4,805 shares during the period. Vanguard Group Inc. boosted its holdings in Transcat by 13.3% in the 3rd quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock valued at $41,674,000 after purchasing an additional 49,828 shares during the period. Kornitzer Capital Management Inc. KS boosted its holdings in Transcat by 103.2% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 63,200 shares of the scientific and technical instruments company’s stock valued at $6,192,000 after purchasing an additional 32,100 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Transcat by 196.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 59,482 shares of the scientific and technical instruments company’s stock valued at $5,827,000 after purchasing an additional 39,432 shares during the period. Finally, Comerica Bank bought a new stake in Transcat in the 3rd quarter valued at $5,221,000. 98.34% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Oppenheimer reissued an “outperform” rating and issued a $125.00 price target (up from $120.00) on shares of Transcat in a report on Thursday, April 18th. TheStreet raised shares of Transcat from a “c+” rating to a “b” rating in a report on Wednesday, January 31st. Finally, HC Wainwright reaffirmed a “buy” rating and set a $124.00 price objective on shares of Transcat in a report on Tuesday, April 16th.

Transcat Price Performance

Shares of NASDAQ:TRNS traded down $0.01 during midday trading on Friday, reaching $109.83. 60,743 shares of the company’s stock were exchanged, compared to its average volume of 38,680. The company’s 50 day simple moving average is $108.73 and its two-hundred day simple moving average is $102.61. The firm has a market capitalization of $969.80 million, a PE ratio of 84.49 and a beta of 0.59. Transcat, Inc. has a 12 month low of $74.89 and a 12 month high of $116.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.81 and a current ratio of 3.37.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $65.17 million during the quarter, compared to analysts’ expectations of $63.36 million. Transcat had a net margin of 4.16% and a return on equity of 9.32%. Equities research analysts expect that Transcat, Inc. will post 1.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Transcat

In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $111.30, for a total value of $556,500.00. Following the completion of the sale, the chief executive officer now owns 108,478 shares in the company, valued at approximately $12,073,601.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $111.30, for a total value of $556,500.00. Following the completion of the sale, the chief executive officer now owns 108,478 shares in the company, valued at approximately $12,073,601.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Lee D. Rudow sold 2,373 shares of the firm’s stock in a transaction dated Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the transaction, the chief executive officer now directly owns 103,688 shares in the company, valued at approximately $11,553,953.84. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,073 shares of company stock worth $900,023. 4.20% of the stock is currently owned by corporate insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.